1. Home
  2. IOVA vs UPBD Comparison

IOVA vs UPBD Comparison

Compare IOVA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.39

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.47

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
UPBD
Founded
2007
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
968.6M
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
IOVA
UPBD
Price
$2.39
$19.47
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$10.45
$32.25
AVG Volume (30 Days)
12.6M
769.6K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
7.91%
EPS Growth
N/A
N/A
EPS
N/A
1.45
Revenue
$250,425,000.00
$4,577,844,000.00
Revenue This Year
$60.71
$10.45
Revenue Next Year
$59.52
$8.03
P/E Ratio
N/A
$13.58
Revenue Growth
175.62
7.48
52 Week Low
$1.64
$15.82
52 Week High
$6.50
$30.62

Technical Indicators

Market Signals
Indicator
IOVA
UPBD
Relative Strength Index (RSI) 45.56 59.15
Support Level $2.29 $17.36
Resistance Level $2.80 $20.08
Average True Range (ATR) 0.18 0.75
MACD -0.05 0.25
Stochastic Oscillator 13.57 77.05

Price Performance

Historical Comparison
IOVA
UPBD

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: